The problem of early mortality in pneumococcal pneumonia: A study of risk factors

European Respiratory Journal

Volumn 46, Issue 2, 2015, Pages 561-564

  Burgos, Joaquín ^a   Luján, Manel ^b   Larrosa, M Nieves ^a   Pedro Botet, M Luisa ^b   Fontanals, Dionisia ^b   Quesada, M Dolores ^b   Lung, Mayli ^a   Bermudo, Guadalupe ^b   Almirante, Benito ^a   Falcó, Vicenç ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE; ANTIINFECTIVE AGENT;

ADULT; BACTERIAL LOAD; COMORBIDITY; DISEASE PREDISPOSITION; HUMAN; LETTER; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; MULTICENTER STUDY; PLEURA FLUID; PRIORITY JOURNAL; RISK FACTOR; SEROTYPE; SEROTYPING; SPAIN; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; THORAX RADIOGRAPHY; ADOLESCENT; AGED; CLINICAL TRIAL; EPIDEMIOLOGY; FEMALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PNEUMONIA, PNEUMOCOCCAL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PNEUMONIA, PNEUMOCOCCAL; RISK FACTORS; SPAIN; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 84938848307     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00034415     Document Type: Letter

References (15)

1. Varon E, Mainardi JL, Gutmann L. Streptococcus pneumoniae: still a major pathogen. Clin Microbiol Infect 2010; 16: 401.
2. Austrian R, Gold J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med 1964; 60: 759-776.
3. Ricketson LJ, Nettel-Aguirre A, Vanderkooi OG, et al. Factors influencing early and late mortality in adults with invasive pneumococcal disease in Calgary, Canada: a prospective surveillance study. PLoS One 2013; 8: e71924.
4. Alanee SR, McGee L, Jackson D, et al. Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin Infect Dis 2007; 45: 52-54.
5. Burgos J, Larrosa MN, Martinez A, et al. Impact of influenza season and environmental factors on the clinical presentation and outcome of invasive pneumococcal disease. Eur J Clin Microbiol Infect Dis 2015; 34: 177-186.
6. Weinberger DM, Harboe ZB, Sanders EA, et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis 2010; 51: 692-699.
7. Naucler P, Darenberg J, Morfeldt E, et al. Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia. Thorax 2013; 68: 571-579.
8. Vernatter J, Pirofski LA. Current concepts in host-microbe interaction leading to pneumococcal pneumonia. Curr Opin Infect Dis 2013; 26: 277-283.
9. Weinberger DM, Trzcinski K, Lu Y-J, et al. Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathog 2009; 5: e1000476.
10. Weiser JN, Kapoor M. Effect of intrastrain variation in the amount of capsular polysaccharide on genetic transformation of Streptococcus pneumoniae: implications for virulence studies of encapsulated strains. Infect Immun 1999; 67: 3690-3692.
11. Sanchez CJ, Hinojosa CA, Shivshankar P, et al. Changes in capsular serotype alter the surface exposure of pneumococcal adhesins and impact virulence. PLoS One 2011; 6: e26587.
12. Klemets P, Lyytikainen O, Ruutu P, et al. Invasive pneumococcal infections among persons with and without underlying medical conditions: implications for prevention strategies. BMC Infect Dis 2008; 8: 96.
13. Marrie TJ, Wu L. Factors influencing in-hospital mortality in community-acquired pneumonia: a prospective study of patients not initially admitted to the ICU. Chest 2005; 127: 1260-1270.
14. Aspa J, Rajas O, Rodriguez de Castro F, et al. Impact of initial antibiotic choice on mortality from pneumococcal pneumonia. Eur Respir J 2006; 27: 1010-1019.
15. Martinez JA, Horcajada JP, Almela M, et al. Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2003; 36: 389-395.